Abstract:Objective This study aimed to evaluate the efficacy and safety of Trigeminal Ganglion Stimulation for the treatment of trigeminal herpes zoster-associated pain (ZAP). Methods Patients diagnosed with Trigeminal herpes zoster at the Department of Pain Management, Henan Provincial People's Hospital between January 2021 and December 2021were selected. Numerical pain scales and complications were analyzed during short-term stimulation and long-term follow-up. Treatment effectiveness was defined as pain relief of more than 50%. Results A total of 19 patients were enrolled. The NRS before surgery was 6.4±1.3, the mean indwelling time of the electrode was 5.2 ± 1.3 days, the NRS of pain after electrode removal was 2.8±1.1. The effective rate was 73.7%. The pain severity after treatment was significantly lower than that before treatment (P < 0.05). No serious complications occurred in all patients. The median follow-up time of was 70 days (range 28-370 days). By the last follow-up, 18 patients had complete remission (NRS ≤ 3), with a complete remission rate of 94.7%. Conclusion Trigeminal ganglion stimulation can relieve trigeminal ZAP quickly. The incidence of complications was low and long-term efficacy was good. It is a safe and effective treatment for trigeminal ZAP.